Minnesota marijuana regulators have taken the first step towards setting rules for the legal market. An advocacy group argues that Medicare should consider controversial patent maneuvers for a drug that will cost the program nearly $2 billion by 2026. The Pennsylvania House Committee has approved a Senate-passed bill allowing medical marijuana growers to sell directly to patients. A drugmaker and its CEO, who once defended Martin Shkreli for raising drug prices, have settled allegations of underpaying Medicaid rebates. A key House committee will consider ending marijuana testing for federal job applicants and lifting the ban on D.C. cannabis sales. California healthcare provider's move highlights the pitfalls of Medicare Advantage. Medicare officials plan to claw back money from certain hospitals to remedy overpayments related to the 340B program. The Federal Sentencing Commission's new marijuana guidelines directing judges to treat past convictions more leniently have officially taken effect. Drugmakers are upset over a new program allowing Medicare to negotiate drug prices. A key Senate panel will consider policies to regulate pharmacy middlemen and reduce medication costs.
A key Senate panel announced it will consider policies to regulate pharmacy middlemen and ensure patients pay less for medications. https://t.co/AvsM4zvVlh
Drugmakers are up in arms over a new program allowing Medicare to negotiate prices on some drugs. The real scandal, of course, is the absurd prices the companies set for these drugs’ sale in the United States, when they are sold for so much less elsewhere. https://t.co/ffeAuxZYIA
Federal Sentencing Commission's New Marijuana Guidelines Directing Judges To Treat Past Convictions More Leniently Officially Take Effect https://t.co/oojdpeJaN3
Medicare officials are moving forward with a plan to claw back money from certain hospitals to try to remedy overpayments related to the 340B program. https://t.co/qH4BXvx5hm
California healthcare provider's move shows pitfalls of Medicare Advantage https://t.co/fPa6tajT1k https://t.co/SIEOdJHIbC
Key House Committee Will Consider Ending Marijuana Testing For Federal Job Applicants And Lifting D.C. Cannabis Sales Ban https://t.co/nlzvqAiJ3I
A drugmaker and its chief executive — who once defended Martin Shkreli for raising drug prices — agreed to settle allegations of purposely underpaying Medicaid rebates. https://t.co/k0inql4lIB
Pennsylvania House Committee Approves Senate-Passed Bill To Let Medical Marijuana Growers Sell Directly To Patients https://t.co/RSrS3fPJUC
An advocacy group argues that Medicare should factor in controversial patent maneuvers for one drug that will have cost the program nearly $2 billion in additional spending by 2026. https://t.co/xBuNLNspDi
Minnesota Marijuana Regulators Take First Step Toward Setting Rules For Legal Market https://t.co/ZuqiUKOqKp